Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
Prescription Digital Therapeutics
All Newsletters
224 articles
16 of 23
That weird FDA de-regulatory notice.
3.19.21
6
min. Read
Blues’ verdict on PDTs: No. Pharma digital spin-offs.
3.12.21
7
min. Read
Curious move by BCBSMA on PDTs. Payers talk reimbursement.
3.05.21
7
min. Read
Another Rx DTx quietly launches. Pipeline changes.
2.26.21
6
min. Read
2021 Prescription DTx report. Headspace’s 2020 prediction.
2.19.21
8
min. Read
Sharecare SPAC. Akili strategy. Pear was almost a fund.
2.12.21
8
min. Read
Apple, Pear studies. Bills for DTx Medicaid reimbursement.
2.05.21
6
min. Read
Pear DTC campaign. Happify-Almirall.
1.29.21
7
min. Read
2022: CPT codes for remote therapeutics.
1.22.21
5
min. Read
Breakthrough reimbursement. AliveCor growth. Pear DME.
1.15.21
8
min. Read
1 of 23